11 – 20 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2012
-
Mark
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
(
- Contribution to journal › Article
-
Mark
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth
(
- Contribution to journal › Article
-
Mark
Copy Number Defects of G1-Cell Cycle Genes in Neuroblastoma are Frequent and Correlate with High Expression of E2F Target Genes and a Poor Prognosis
(
- Contribution to journal › Article
-
Mark
Stability of PCR Targets for Monitoring Minimal Residual Disease in Neuroblastoma
(
- Contribution to journal › Article
-
Mark
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
(
- Contribution to journal › Article
- 2009
-
Mark
The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo
(
- Contribution to journal › Article
-
Mark
Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy.
(
- Contribution to journal › Article
- 2008
-
Mark
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is'-down-regulated by MYCN
(
- Contribution to journal › Article
- 2007
-
Mark
Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »